Key Record Dates
ClinicalTrials.gov Identifier: | NCT03485547 |
---|---|
Brief Title: | Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) |
First Submitted : | March 27, 2018 |
First Submitted that Met QC Criteria : | March 30, 2018 |
First Posted : | April 2, 2018 |
Last Update Submitted that Met QC Criteria : | February 12, 2024 |
Last Update Posted : | February 13, 2024 |